These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6304295)

  • 1. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding.
    Glossmann H; Ferry DR; Lübbecke F; Mewes R; Hofmann F
    J Recept Res; 1983; 3(1-2):177-90. PubMed ID: 6304295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
    Glossmann H; Ferry DR
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of multiple receptor sites within the putative calcium channel.
    Ferry DR; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):80-3. PubMed ID: 6292744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA; Coutinho OP; Carvalho AP
    J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of putative calcium channels in skeletal muscle microsomes.
    Ferry DR; Glossmann H
    FEBS Lett; 1982 Nov; 148(2):331-7. PubMed ID: 6295810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
    FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channels: evidence for oligomeric nature by target size analysis.
    Ferry DR; Goll A; Glossmann H
    EMBO J; 1983; 2(10):1729-32. PubMed ID: 6315398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain.
    Peroutka SJ; Allen GS
    J Neurosurg; 1983 Dec; 59(6):933-7. PubMed ID: 6631515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL; Schwartz A
    Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites.
    Ferry DR; Goll A; Gadow C; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):183-7. PubMed ID: 6092974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
    Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
    Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
    Galizzi JP; Fosset M; Lazdunski M
    Eur J Biochem; 1984 Oct; 144(2):211-5. PubMed ID: 6092067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new class of calcium entry blockers defined by 1,3-diphosphonates. Interactions of SR-7037 (belfosdil) with receptors for calcium channel ligands.
    Rossier JR; Cox JA; Niesor EJ; Bentzen CL
    J Biol Chem; 1989 Oct; 264(28):16598-607. PubMed ID: 2550449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranes.
    Rampe D; Luchowski E; Rutledge A; Janis RA; Triggle DJ
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1452-60. PubMed ID: 2444320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.